Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous NSCLC 1Colonic Neoplasms 1CRC 1

Interventions

Oxaliplatin 6tislelizumab 3Irinotecan 3Fluorouracil 3Chemotherapy, Adjuvant 3Capecitabine 3sintilimab 2raltitrexed 2pembrolizumab 2Surgical Procedures, Operative 2Specimen Handling 2Neoadjuvant Therapy 2HMPL-013 2spartalizumab 1rimegepant sulfate 1encorafenib 1cemiplimab 1balstilimab 1XELOX 1Surgical Fixation Devices 1Radiofrequency Ablation 1Propranolol 1Preoperative Exercise 1Pemetrexed 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Mortality 1Magnetic Resonance Spectroscopy 1Leucovorin 1Laparoscopy 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Colonic Neoplasms × HLX07 × Clear all
NCT07358585 2026-01-22

A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer

Shanghai Henlius Biotech

Phase 1/2 Not yet recruiting
126 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡